Literature DB >> 30138298

Association of Sex With Clinical Outcome in Critically Ill Sepsis Patients: A Retrospective Analysis of the Large Clinical Database MIMIC-III.

Jinghong Xu1,2, Li Tong1, Jiyou Yao1,3, Zilu Guo4, Ka Yin Lui1, XiaoGuang Hu1, Lu Cao5, Yanping Zhu1, Fa Huang1,3, Xiangdong Guan1, Changjie Cai1.   

Abstract

INTRODUCTION: The objective of our study was to explore the association between sex and clinical outcome in sepsis patients in a large, diverse population.
MATERIALS AND METHODS: We analyzed 6,134 adult patients with sepsis from the critical care units of Beth Israel Deaconess Medical Center between 2001 and 2012. Study data were retrospectively extracted from Medical Information Mart for Intensive Care-III, a multiparameter intensive care database.
RESULTS: There were 2,677 (43.6%) female and 3,457 (56.4%) male patients. Compared with female patients, male patients with sepsis had a higher 1-year mortality rate (55.6% vs. 51.4%, P = 0.001), and so did the 90-day mortality rate (45.1% vs. 42.1%, P = 0.018). 33.8% of male and 31.3% of female patients with sepsis died during hospitalization (P = 0.041). The median length of hospitalization and intensive care unit (ICU) stay for male patients was 19.54 and 7.54 days, while that for female patients was 16.49 and 6.75 days (P < 0.001, P = 0.002, respectively). Male patients were more likely to require dialysis therapy (P = 0.109), ventilation support (P = 0.012) and more vasoactive agents (dopamine P = 0.113, norepinephrine P = 0.016, and epinephrine P = 0.093) during the ICU period than female patients. Our Cox proportional hazard regression model confirmed that the risk of death within 1 year of ICU admission in male patients is 1.083 times that in female.
CONCLUSION: Female patients with sepsis have better clinical outcomes than male patients in terms of mortality and length of hospitalization and ICU stay.

Entities:  

Year:  2019        PMID: 30138298      PMCID: PMC6687414          DOI: 10.1097/SHK.0000000000001253

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


INTRODUCTION

Sepsis is a common clinical syndrome characterized by life-threatening organ dysfunction caused by a dysregulated host response to infection (1). Despite increased research efforts and continuous exploration of the pathophysiology of sepsis, this illness is still a major cause of death in the ICU and remains a public health issue that affects quality of life for many sufferers around the world every year (2–4). Previous studies have confirmed that patients of different sex show different clinical manifestations and outcomes during infection with bacteria, viruses, and fungi (5). The literature has documented that the way men and women respond to infection is different. Women can produce better humoural and cellular immune responses after infection than men but are also prone to autoimmune diseases (6, 7). Epidemiological studies consistently report a higher prevalence of sepsis in males relative to that in females (8). However, the influence of sex on the clinical outcomes of sepsis is still highly controversial. The results of human studies focusing on the impact of sex on sepsis-associated mortality are inconsistent. A prospective, observational clinical study (9) in Germany concluded that the mortality of female sepsis patients is higher than that of male sepsis patients. Another prospective study by Nasir et al. (10) reported a completely opposite conclusion; their study showed that higher levels of plasma IL-6 lead to higher mortality in male patients with sepsis. However, a recent study declared that there is no effect from sex on the clinical outcome of patients with sepsis (11). Thus far, there is no conclusive consensus on this issue. Clinicians are often confused by the different perspectives and thus cannot correctly predict the prognosis. Understanding this problem is of great significance to comprehensive prevention and treatment of sepsis. To obtain more convincing results, this problem must be studied in a large, diverse group of people. In our study, we aimed to gain insight into sex-related differences in sepsis outcomes in large sample populations.

PATIENTS AND METHODS

Database

This article aimed to reveal the impact of sex on the clinical outcome of sepsis using data from Medical Information Mart for Intensive Care III (MIMIC-III) (12, 13), which is a large, publicly available database that includes unidentified health-related data from approximately sixty thousand patients who were admitted to critical care units of the Beth Israel Deaconess Medical Center (BIDMC). MIMIC is made available largely through the work of researchers at the Massachusetts Institute of Technology (MIT) Laboratory for Computational Physiology and collaborating research groups. After completing the National Institutes of Health web-based training course “Protecting Human Research Participants,” we obtained approval to access the database (Certification Number: 2093226).

Study population

All patients diagnosed with “sepsis,” “severe sepsis,” or “septic shock” in the MIMIC-III clinical database were potentially eligible for the present analysis. The only exclusion criterion was an age less than 18 years old.

Data extraction and management

Data on the following aspects were extracted: age, ethnicity, Simplified Acute Physiology Score (SAPS), sequential organ failure assessment (SOFA) score, admission type and location, first ICU service, date of ICU admission and discharge, date of birth and death, mechanical ventilation time, amount of vasoactive drug applied, and dialysis demand. The database had obscured the true ages of patients over 89 years old. The median age of those patients was 91.5 years, and we used this value as a surrogate age for those patients. Both the SOFA score and SAPS were computed using the code directly provided by Johnson et al. (14). The primary endpoint in our study was 1-year mortality, which was defined as death observed within 1 year after ICU admission. The hospital and ICU length of stay (LOS) were selected as the secondary outcomes, with the former calculated from the date of admission and discharge and the latter extracted directly from the database. Hospitalization and 90-day mortality were also assessed. For patients who were discharged alive, we extracted the date of death from the social security database to determine out-of-hospital mortality. Data extraction was accomplished using structure query language (SQL) by PostgreSQL tools (v9.6; PostgreSQL Global Development Group). Data were extracted from the following tables: ADMISSIONS, ICUSTAYS, PATIENTS, CHARTEVENTS, and DIAGNOSIS_ICD.

STATISTICAL ANALYSIS

If the measurement data were normally distributed and the variance was homogeneous, the data were described as the mean ± standard deviation and compared between groups using a t test. If the requirements were not satisfied, data were represented by the median and interquartile range, and the Wilcoxon rank-sum test was used for comparisons between groups. Numeration data were expressed as absolute values and percentages; the chi-square test or Fisher exact test was chosen for statistical analyses as appropriate. Survival analysis was performed with the log-rank test to determine whether sex affects 1-year mortality. Kaplan–Meier survival curves were generated. Univariate analysis was carried out between survivors and non-survivors to screen variables associated with 1-year mortality by Pearson chi-square test. The variables with P < 0.1 in the univariate analysis were included in the Cox proportional hazard regression model as covariates to determine the factors that impact the 1-year survival rate. All data analyses were performed by SPSS software (v21.0; IBM, Armonk, NY); a two-tailed P < 0.05 was considered statistically significant.

RESULTS

Demographic and clinical characteristics

Results from the univariate analysis of patients’ basic information stratified by sex are summarized in Table 1. There were 2,677 female and 3,457 male patients, accounting for 43.6% and 56.4% of the total population, respectively. Male patients were slightly younger than female patients, and the proportion of White (75.1%, P = 0.002) and Hispanic or Latino (4.1%, P = 0.001) patients was higher while the proportion of Asian patients was lower among male patients than among female patients. The proportion of male patients from the medical intensive care unit (MICU) was lower than that of female patients (P < 0.001), while in the cardiac surgery recovery unit (CSRU) and surgical intensive care unit (SICU), the proportion of men was higher than that of women (P = 0.003, P = 0.004, respectively). There were differences in admission type and location between men and women (P = 0.003 for each). The SOFA score of the first day in the ICU was higher for men (P < 0.001), while there was no significant difference in the SAPS between the two groups of men and women (P = 0.113).
Table 1

Univariate analysis of demographic and hospital characteristics by gender category

Female (2,677)Male (3,457)P value
Age, n (%)69 (57,81)67 (56,79)<0.001
 <45259 (9.7)321 (9.3)0.605
 45–64820 (30.6)1,187 (34.4)0.002
 65–891,349 (50.4)1,766 (51.1)0.591
 >90249 (9.3)181 (5.2)<0.001
Ethnicity, n (%)<0.001
 White1,915 (71.5)2,597 (75.1)0.002
 Black369 (13.8)273 (7.9)<0.001
 Hispanic or Latino70 (2.6)143 (4.1)<0.001
 Asian85 (3.2)119 (3.4)0.563
 Other238 (8.9)325 (9.4)0.492
First ICU service, n (%)<0.001
 CCU238 (8.9)318 (9.2)0.677
 MICU1,854 (69.3)2,230 (64.5)<0.001
 CSRU78 (2.9)151 (4.4)0.003
 SICU507 (18.9)758 (21.9)0.004
Marital status, n (%)<0.001
 Married930 (34.7)1,883 (54.5)<0.001
 Single/separated/divorced/widow1,634 (61.0)1,408 (40.7)<0.001
 Unknown113 (4,2)166 (4.8)0.279
Insurance, n (%)<0.001
 Government45 (1.7)72 (2.1)0.254
 Medicaid/Medicare2,039 (76.2)2,410 (69.7)<0.001
 Private587 (21.9)950 (27.5)<0.001
 Self-pay6 (0.2)25 (0.7)0.006
Admission type, n (%)0.003
 Elective75 (2.8)155 (4.5)0.001
 Emergency2,562 (95.7)3,247 (93.8)0.002
 Urgent40 (1.5)55 (1.6)0.761
Admission location, n (%)0.003
 Referral684 (25.6)805 (24.7)0.432
 Emergency1,375 (51.4)1,578 (48.3)0.022
 Transfer618 (23.1)881 (27)0.001
 SOFA*6.97 ± 3.527.29 ± 3.75<0.001
 SAPS*21.39 ± 5.7321.06 ± 5.600.113

*Score calculated within 24 h after entering ICU.

SAPS indicates the simplified acute physiology score; SOFA, the sequential organ failure score; ICU, intensive care unit; SICU, surgical intensive care unit; CCU, cardiac care unit; CSRU, cardiac surgery recovery unit; MICU, medical intensive care unit.

Univariate analysis of demographic and hospital characteristics by gender category *Score calculated within 24 h after entering ICU. SAPS indicates the simplified acute physiology score; SOFA, the sequential organ failure score; ICU, intensive care unit; SICU, surgical intensive care unit; CCU, cardiac care unit; CSRU, cardiac surgery recovery unit; MICU, medical intensive care unit.

Univariate analysis of clinical outcomes

Calculations of the mortality rates and the hospital and ICU LOS were stratified by sex and are summarized in Table 2. Among male patients, 55.6% died within 1 year after admission to the ICU, which was significantly higher than the percentage of female patients (51.4%, P = 0.001). Additionally, 33.8% of male and 31.3% of female patients died during hospitalization (P = 0.041). Furthermore, there was a significant difference in the 90-day mortality rate between men and women (45.1% vs. 42.1%, respectively, P = 0.018). Considering that age represents an important issue in the female group, we compared 1-year mortality between males and females in different age groups (Fig. 1). We established four life periods according to the child-bearing, menopause, senescence, and longevity periods in females. The mortality rate of males and females increased with age. In patients younger than 90 years old, males had significantly higher 1-year mortality than females. The median length of hospitalization and ICU stay for male patients with sepsis was 19.54 and 7.54 days, respectively, while that for female patients was 16.49 and 6.75 days (P < 0.001, P = 0.002 respectively). The Kaplan–Meier curve for 1-year survival by sex is shown in Figure 2.
Table 2

Univariate analysis of requirement of organ support therapy by gender category

FemaleMaleP value
Ventilation (n, %)1,345 (50.2)1,848 (53.5)0.012
Ventilation duration (h)*106.00 (33.88, 236.68)109.25 (32.66, 245.01)0.606
Dialysis, n (%)819 (30.6)1,124 (32.5)0.109
Vasoactive agent
 Dopamine, n (%)279 (10.4)341 (9.9)0.472
 Dopamine (mg/kg)3.07 (0.89, 10.45)4.27 (1.15, 12.42)0.113
 Norepinephrine, n (%)1,329 (49.6)1,638 (47.4)0.079
 Norepinephrine (mg/kg)0.15 (0.04, 0.48)0.18 (0.05, 0.54)0.016
 Epinephrine, n (%)61 (2.3)98 (2.8)0.174
 Epinephrine (mg/kg)0.03 (0.01, 0.10)0.06 (0.01, 0.11)0.093

*From the beginning of mechanical ventilation to the oxygen therapy start.

†The total amount of vasoactive drugs required per kilogram of weight.

Fig. 1

Comparison of 1-year mortality between male and female sepsis patients in different age groups.

Fig. 2

Kaplan–Meier curve for 1-year survival stratified by gender.

Univariate analysis of requirement of organ support therapy by gender category *From the beginning of mechanical ventilation to the oxygen therapy start. †The total amount of vasoactive drugs required per kilogram of weight. Comparison of 1-year mortality between male and female sepsis patients in different age groups. Kaplan–Meier curve for 1-year survival stratified by gender. Kaplan–Meier curve for survival stratified by gender over a 1-year period. The survival rate was significantly higher in the female group than in the male group (P = 0.007 by log-rank test). We studied the requirements of the two groups for mechanical ventilation, dialysis, and vasoactive drugs during the ICU period. The results of the comparison are shown in Table 3. Among male patients, 53.5% required mechanical ventilation. In comparison, the ratio of female patients who required mechanical ventilation was lower (50.2%, P = 0.012). There was no difference in the number of patients who required dialysis or vasoactive drugs between the two groups. The total amount of dopamine, norepinephrine, and epinephrine required per kilogram of weight for men during their ICU stay was more than that for women (P = 0.113, P = 0.016, and P = 0.093, respectively) (Fig. 3).
Table 3

Univariate analysis of clinical outcomes by gender category

FemaleMaleP
Mortality, n (%)
 Hospital mortality839 (31.3)1,169 (33.8)0.041
 30-day mortality888 (33.2)1,219 (35.3)0.087
 90-day mortality1,127 (42.1)1,571 (45.1)0.018
 One-year mortality1,327 (51.4)1,923 (55.6)0.001
Length of stay (day)
 Hospital LOS10.44 (5.73,20.84)12.06 (6.13,24.01)<0.001
 ICU LOS3.37 (1.80,8.05)3.80 (1.88,8.95)0.002

ICU indicates intensive care unit; LOS, length of stay.

Fig. 3

Result of the Cox proportional hazard regression analysis.

Univariate analysis of clinical outcomes by gender category ICU indicates intensive care unit; LOS, length of stay. Result of the Cox proportional hazard regression analysis. Each horizontal line represents the 95% CI range, and the small black spots in the middle of the crosses represent the OR value.

Cox proportional hazards analyses of 1-year mortality

After comparing the variables between 1-year survivors and non-survivors in the univariate analysis (see Table 4), we chose to input sex, race, first ICU service, marital status, insurance, admission location, SAPS and SOFA scores but not admission type into the Cox proportional hazards regression model (see Fig. 2). Our multivariate regression model revealed relations between sex and 1-year mortality; the risk of death within 1 year in men was 0.083-times higher than that in women (P = 0.031, OR = 1.083, 95% CI 1.007–1.167). In addition, advanced age and higher admission SAPS and SOFA score were correlated with increased mortality risk within 1 year (P < 0.001).
Table 4

Univariate analysis of demographic and hospital characteristics by category of 1-year outcome

SurvivalNon-survivalP
Gender67 (55, 79)70 (58, 81)0.001
Female1,300 (48.6)1,377 (51.4)
Male1,534 (44.4)1,923 (55.6)
Age<0.001
 <45387 (66.7)193 (33.3)<0.001
 45–641,080 (53.8)929 (46.2)0.003
 65–891,221 (39.2)1,894 (60.8)0.127
 >90146 (34.0)284 (66.0)<0.001
Ethnicity0.026
 White2,066 (45.8)2,466 (54.2)0.354
 Black321 (50.0)321 (50.0)0.016
 Hispanic or Latino110 (51.6)103 (48.4)0.148
 Asian100 (49.0)104 (51.0)0.380
 Other237 (42.1)326 (57.9)<0.001
First ICU Service0.01
 CCU227 (40.8)329 (59.2)0.088
 MICU1,888 (46.2)2,196 (53.8)0.095
 CSRU99 (43.2)130 (56.8)0.113
 SICU620 (49.0)645 (51.0)0.994
Marital status, n (%)<0.001
 Married1,275 (45.0)1,538 (46.6)0.205
 Single/separated/divorced/widow1,459 (51.5)1,583 (48.0)0.006
 Unknown100 (3.5)179 (5.4)<0.001
Insurance, n (%)<0.001
 Government75 (2.6)42 (1.3)<0.001
 Medicaid/Medicare1,906 (67.3)2,543 (77.1)<0.001
 Private837 (29.5)700 (21.2)<0.001
 Self-pay16 (0.6)15 (0.5)0.545
Admission type0.87
 Elective104 (45.2)126 (54.8)0.125
 Emergency2,684 (46.2)3,125 (53.8)0.076
 Urgent46 (48.4)49 (51.6)0.390
Admission location<0.001
 Referral784 (51.0)753 (49.0)0.008
 Emergency1,376 (45.1)1,673 (54.9)0.004
 Transfer674 (43.5)874 (56.5)<0.001
 SPAS19 (15, 23)22 (18, 26)<0.001
 SOFA5 (3, 8)7 (3, 8)<0.001

*The patient is still alive after a year of ICU entry.

†The patient died within 1 year after ICU entry.

ICU indicates intensive care unit; SICU, surgical intensive care unit; CCU, cardiac care unit; CSRU, cardiac surgery recovery unit; MICU, medical intensive care unit.

Univariate analysis of demographic and hospital characteristics by category of 1-year outcome *The patient is still alive after a year of ICU entry. †The patient died within 1 year after ICU entry. ICU indicates intensive care unit; SICU, surgical intensive care unit; CCU, cardiac care unit; CSRU, cardiac surgery recovery unit; MICU, medical intensive care unit.

DISCUSSION

At present, there are many studies on the relationship between sex and clinical outcomes in patients with sepsis, but the results are still controversial. Hence, it is necessary to further study this problem using a database. All data in the MIMIC database are directly imported by the medical record system or recorded by the medical staff. We then extracted the relevant data according to our research requirements; the only inclusion criterion was an adult patient diagnosed with sepsis, irrespective of his or her primary disease, disease severity, and special treatment. Data storage and assessment were performed by different teams. Since data were already recorded in the database before we formed the research plan, our subjective consciousness did not interfere with patient inclusion and treatment, which ensures that our data are true and that our results are credible. However, selection bias or subjective interference were difficult to avoid in previous retrospective studies and may affect the research results to some extent. In addition, the population number in our research study is four times or more than that in previous studies, and our study duration was also longer. Therefore, some of the confounding factors are more balanced among the two groups of men and women. Animal studies have also indicated that females appear to have a survival advantage in terms of both immunologic and cardiovascular responses (15). The LOS in the ICU or hospital was longer in male sepsis patients than in female sepsis patients, which has been overlooked by many studies. We agree with Sakr et al.'s (16) interpretation of this finding that there may be a sex-related bias in the treatment choice. Some studies have reached a consensus that male patients require higher intensity ICU support treatment than female patients (17). The ICU admission rates among men were higher than those among women, and men were also more likely than women to receive advanced therapy and undergo invasive procedures. In addition, male patients required more norepinephrine than women to correct hemodynamic abnormalities. That is, hypotension in male patients with sepsis is more difficult to correct than that in female patients. Some researchers have reported that fewer females receive antibiotics than males (18), and females were significantly less likely than males to receive antibiotics within 3 h (19). The difference in the use of antibiotics may be related to the different infection location. Some studies paid attention to this issue and observed that there were clear differences in infection sites based on sex. Two primary sites of infection emerged: the chest (including pneumonia and respiratory tract infection) and the urinary tract. Females were less likely to have respiratory infections than males, but females more commonly developed sepsis from genitourinary sources than males (18, 20). This outcome may be caused by lifestyle and anatomical differences between men and women. After comprehensive analysis of our data and related literature, we concluded that the difference in 1-year mortality between men and women may be due to postintensive care syndrome (PICS). PICS describes new or worse health problems after critical illness that remain after patients leave the hospital (21). These problems can be related to the body, thoughts, feelings, or mind of patients and may cause physical weakness and affect disease recovery, further influencing the long-term survival rate of patients. Some surveys have shown that the incidence of PICS in males is significantly higher than that in females (22). Sepsis, mechanical ventilation, and invasive operation are high-risk factors for PICS occurrence (23). As mentioned above, male patients are more likely to receive more aggressive treatment in the ICU, including mechanical ventilation, deep venous and artery puncture, and dialysis, than female patients. These treatments also increase the risk of PICS occurrence in male patients. At present, the clinical interpretation of sex differences in the outcome of sepsis is still undetermined. The mainstream view regards the difference in the outcome of sepsis based on sex to be caused by different levels of hormones in the body (24, 25). Animal studies have confirmed that oestrogen, especially oestradiol, can inhibit the inflammatory response and regulate the immune system to achieve a balance of inflammatory and anti-inflammatory reactions and promote the repair of damaged tissues, thereby protecting the organs (26, 27). Oestrogen has also been proven to have a direct protective effect on vascular endothelial cells (VECs), which play an important role in microcirculation. It was reported that oestrogen can promote the growth of VECs and protect the normal function of blood vessels (28). Oestrogen can also inhibit endothelial cell apoptosis, induce endothelial cell proliferation and migration, and promote microvessel regeneration (29). In addition to the effect of oestrogen on the inflammatory response, whether the protective effect of oestrogen on endothelial cells underlies the differences in sex-based sepsis outcomes requires more scientists to investigate. Although our research is based on a large, diverse population, this is actually a retrospective single-center study. Limited by our current capabilities and the extent to which the database can be used, our research discovered a phenomenon but cannot fully explain its pathophysiological mechanism. The inflammatory response has a strong effect on the pathogenesis of sepsis and is closely related to the mortality rate. However, in this study, we did not extract indicators of the inflammatory response, such as the level of inflammatory factors, in patients. Therefore, we cannot directly compare the inflammatory response between male and female patients. In patients with sepsis, the indicators of VEC function are not routinely tested. Thus, we should focus on whether there is a difference in endothelial cell function between male and female patients with sepsis in a future study. The mechanism of the relationship between sex and clinical outcomes in patients with sepsis also requires further study. A large number of animals and molecular experiments must be carried out to discover the relevant mechanisms, as an understanding of these mechanisms will be of great significance for the prevention and treatment of sepsis.

CONCLUSION

The clinical outcome in women with sepsis is better than that in men with sepsis in terms of mortality and the length of hospitalization and ICU stay.
  29 in total

Review 1.  Fetomaternal immune cross-talk and its consequences for maternal and offspring's health.

Authors:  Petra C Arck; Kurt Hecher
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

Review 2.  Genes that escape from X inactivation.

Authors:  Joel B Berletch; Fan Yang; Jun Xu; Laura Carrel; Christine M Disteche
Journal:  Hum Genet       Date:  2011-05-26       Impact factor: 4.132

3.  Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery.

Authors:  C W Hogue; T Sundt; B Barzilai; K B Schecthman; V G Dávila-Román
Journal:  Anesthesiology       Date:  2001-11       Impact factor: 7.892

Review 4.  Estrogen and the cardiovascular system.

Authors:  A A Knowlton; A R Lee
Journal:  Pharmacol Ther       Date:  2012-03-28       Impact factor: 12.310

5.  The DISPARITY Study: do gender differences exist in Surviving Sepsis Campaign resuscitation bundle completion, completion of individual bundle elements, or sepsis mortality?

Authors:  Tracy E Madsen; James Simmons; Esther K Choo; David Portelli; Alyson J McGregor; Anthony M Napoli
Journal:  J Crit Care       Date:  2014-01-13       Impact factor: 3.425

6.  Sex differences in response to immunonutrition in sepsis.

Authors:  Tsann-Long Hwang; Yu-Mei Yang
Journal:  Nutrition       Date:  2008 Jul-Aug       Impact factor: 4.008

7.  The alteration of inflammatory markers and apoptosis on chronic prostatitis induced by estrogen and androgen.

Authors:  Yu-ling Jia; Xu Liu; Jian-yan Yan; Li-ming Chong; Lei Li; Ai-cui Ma; Li Zhou; Zu-yue Sun
Journal:  Int Urol Nephrol       Date:  2014-09-24       Impact factor: 2.370

8.  Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study.

Authors:  Irit Nachtigall; Sascha Tafelski; Andreas Rothbart; Lutz Kaufner; Maren Schmidt; Andrey Tamarkin; Maxim Kartachov; Daniela Zebedies; Tanja Trefzer; Klaus-Dieter Wernecke; Claudia Spies
Journal:  Crit Care       Date:  2011-06-21       Impact factor: 9.097

9.  The influence of gender on the epidemiology of and outcome from severe sepsis.

Authors:  Yasser Sakr; Cristina Elia; Luciana Mascia; Bruno Barberis; Silvano Cardellino; Sergio Livigni; Gilberto Fiore; Claudia Filippini; Vito Marco Ranieri
Journal:  Crit Care       Date:  2013-03-18       Impact factor: 9.097

10.  MIMIC-III, a freely accessible critical care database.

Authors:  Alistair E W Johnson; Tom J Pollard; Lu Shen; Li-Wei H Lehman; Mengling Feng; Mohammad Ghassemi; Benjamin Moody; Peter Szolovits; Leo Anthony Celi; Roger G Mark
Journal:  Sci Data       Date:  2016-05-24       Impact factor: 6.444

View more
  14 in total

1.  What's New in Shock, August 2019?

Authors:  David Machado-Aranda; Matthew J Delano; Krishnan Raghavendran
Journal:  Shock       Date:  2019-08       Impact factor: 3.454

Review 2.  Sex and Gender Differences in Bacterial Infections.

Authors:  Sara P Dias; Matthijs C Brouwer; Diederik van de Beek
Journal:  Infect Immun       Date:  2022-09-19       Impact factor: 3.609

3.  Temporal trends of medical cost and cost-effectiveness in sepsis patients: a Japanese nationwide medical claims database.

Authors:  Takehiko Oami; Taro Imaeda; Taka-Aki Nakada; Toshikazu Abe; Nozomi Takahashi; Yasuo Yamao; Satoshi Nakagawa; Hiroshi Ogura; Nobuaki Shime; Yutaka Umemura; Asako Matsushima; Kiyohide Fushimi
Journal:  J Intensive Care       Date:  2022-07-14

4.  Sex as a prognostic factor for mortality in critically ill adults with sepsis: a systematic review and meta-analysis.

Authors:  Alba Antequera; Jesus Lopez-Alcalde; Elena Stallings; Alfonso Muriel; Borja Fernández Félix; Rosa Del Campo; Manuel Ponce-Alonso; Pilar Fidalgo; Ana Veronica Halperin; Olaya Madrid-Pascual; Noelia Álvarez-Díaz; Ivan Solà; Federico Gordo; Gerard Urrutia; Javier Zamora
Journal:  BMJ Open       Date:  2021-09-22       Impact factor: 3.006

Review 5.  Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics.

Authors:  Rebecca Shepherd; Ada S Cheung; Ken Pang; Richard Saffery; Boris Novakovic
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

6.  Reduced Risk of Sepsis and Related Mortality in Chronic Kidney Disease Patients on Xanthine Oxidase Inhibitors: A National Cohort Study.

Authors:  Huang-Yu Yang; Yun-Shiuan Olivia Hsu; Tao Han Lee; Chao-Yi Wu; Chung-Ying Tsai; Li-Fang Chou; Hui-Tzu Tu; Yu-Tung Huang; Shang-Hung Chang; Chieh-Li Yen; Meng-Hsuan Hsieh; Cheng-Chia Lee; George Kuo; Chih-Yen Hsiao; Hsing-Lin Lin; Jia-Jin Chen; Tzung-Hai Yen; Yung-Chang Chen; Ya-Chong Tian; Chih-Wei Yang; Gerard F Anderson
Journal:  Front Med (Lausanne)       Date:  2022-01-31

7.  A Nomogram With Six Variables Is Useful to Predict the Risk of Acquiring Carbapenem-Resistant Microorganism Infection in ICU Patients.

Authors:  Jin Zhang; Wanjun Liu; Wei Shi; Xuanxuan Cui; Yu Liu; Zongqing Lu; Wenyan Xiao; Tianfeng Hua; Min Yang
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

Review 8.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

9.  Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia.

Authors:  Lingye Chen; Bryan D Kraft; Victor L Roggli; Zachary R Healy; Christopher W Woods; Ephraim L Tsalik; Geoffrey S Ginsburg; David M Murdoch; Hagir B Suliman; Claude A Piantadosi; Karen E Welty-Wolf
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-09       Impact factor: 6.011

10.  Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort study.

Authors:  Jonas Sunden-Cullberg; Anton Nilsson; Malin Inghammar
Journal:  Intensive Care Med       Date:  2020-01-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.